Dr Mark Vaudin

CEO

Mark is an experienced genome scientist and geneticist, whose expertise is recognised internationally. Mark has been CEO of the AHT since 2013.

Mark joined the AHT as Head of Genetics in 2004 and, following the retirement of the Executive Chairman, undertook the role of Interim Chief Executive from May until December 2006. In January 2007 he was appointed as Deputy Chief Executive and Head of Research and in 2013, Mark was appointed CEO of the AHT. Mark completed his PhD researching aspects of the human genome, under Nobel Laureate Professor Sydney Brenner in Cambridge, and has held key positions in both academic and commercial sectors before joining the AHT.